Promoting Patient Centricity in Neurodegenerative Disease Trials

This white paper discusses the importance of patient and site centricity in clinical trials for neurodegenerative diseases. It outlines how a patient-centric approach can enhance patient engagement, recruitment, compliance, and retention. The document emphasizes the need for site-specific support solutions that facilitate participation while allowing site staff to focus on patient care. It details various strategies for early engagement of patients and caregivers, which can refine study design and endpoints. The paper also highlights the significance of understanding the unique needs of the patient population in neurodegenerative trials, including considerations for diversity and inclusion. Additionally, it addresses the challenges of trial design and the importance of flexibility in study protocols to accommodate the varying abilities of patients. The document provides recommendations for sponsors to incorporate patient voices throughout the drug development process, ensuring that trials are designed with the patients' perspectives in mind.